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Abstract
Background: The flaviviridae family comprises single-stranded RNA viruses that enter cells via clathrin-mediated pH-
dependent endocytosis. Although the initial events of the virus entry have been already identified, data regarding
intracellular virus trafficking and delivery to the replication site are limited. The purpose of this study was to map
the transport route of Zika virus and to identify the fusion site within the endosomal compartment.
Methods: Tracking of viral particles in the cell was carried out with confocal microscopy. Immunostaining of two
structural proteins of Zika virus enabled precise mapping of the route of the ribonucleocapsid and the envelope
and, consequently, mapping the fusion site in the endosomal compartment. The results were verified using RNAi
silencing and chemical inhibitors.
Results: After endocytic internalization, Zika virus is trafficked through the endosomal compartment to fuse in late
endosomes. Inhibition of endosome acidification using bafilomycin A1 hampers the infection, as the fusion is
inhibited; instead, the virus is transported to late compartments where it undergoes proteolytic degradation. The
degradation products are ejected from the cell via slow recycling vesicles. Surprisingly, NH4Cl, which is also believed
to block endosome acidification, shows a very different mode of action. In the presence of this basic compound,
the endocytic hub is reprogrammed. Zika virus-containing vesicles never reach the late stage, but are rapidly
trafficked to the plasma membrane via a fast recycling pathway after the clathrin-mediated endocytosis.
Further, we also noted that, similarly as other members of the flaviviridae family, Zika virus undergoes furin- or furin-
like-dependent activation during late steps of infection, while serine or cysteine proteases are not required for Zika
virus maturation or entry.
Conclusions: Zika virus fusion occurs in late endosomes and is pH-dependent. These results broaden our
understanding of Zika virus intracellular trafficking and may in future allow for development of novel treatment
strategies. Further, we identified a novel mode of action for agents commonly used in studies of virus entry.
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Plain English summary
Zika virus is a mosquito-borne pathogen, which infects
humans. Here, we present how Zika virus hijacks intra-
cellular transport machinery to be delivered to the repli-
cation site. Tracking of single virions revealed that they
follow clathrin-mediated endocytosis to fuse within late
endosomes. Interestingly, we noted that two compounds
commonly used to block endocytosis –bafilomycin A1
and NH4Cl - have a very different activity than previ-
ously anticipated. Bafilomycin A1 disables viral fusion by
alteration of the endosome pH, while NH4Cl completely
rewires the endosomal hub.
Background
Zika virus (ZIKV) is a (+)ssRNA mosquito-borne flavivi-
rus that infects humans [1]. Although it originates from
Africa, it hit the spotlight almost 60 years after its first
discovery, due to massive outbreaks in Micronesia, the
South Pacific Islands, and South America [2–5]. It is
estimated that, since identification of the first case in
South America in May 2015, the total number of human
cases on this continent has reached 1,300,000 [6]. The
rapid spread and neuropathologic complications
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associated with ZIKV infection (microcephaly in new-
borns and Guillain-Barré syndrome in adults [7–9]), in-
dicate an urgent need for research into the biology of
the pathogen.
The initial events of ZIKV entry have been identified [10–
12]; but data regarding its fate thereafter are limited. Upon
attachment to a permissive cell, ZIKV crosses the plasma
membrane via clathrin- and mucolipin-2-dependent endo-
cytosis, accompanied by formation of LY6E tubules [13, 14].
The dependence of ZIKV on endocytosis has been con-
firmed in a variety of cell models [15].
Clathrin-mediated endocytosis (CME) is initiated by ac-
tivation of receptor proteins, followed by recruitment of
the AP2 adaptor complex, which induces assembly of the
clathrin coat and formation of membrane niches of~ 100
nm [16]. As the invagination deepens, dynamin (GTPase),
oligomerizes around the bud neck, cleaves it from the cell
surface, and creates an intracellular vesicle [17, 18], which
at first is translocated through the actin cortex and then
trafficked along microtubules [19]. As the vesicle travels
across the cell, it matures. First, the clathrin coat is re-
moved; the uncoated vesicles may then fuse with each
other or be delivered to the first (and major) sorting sta-
tion, i.e., early endosomes. Vesicle trafficking is directed
by small membrane GTPases belonging to the Rab family
[20]. Early endosomes are characterized by the presence
of early endosome antigen 1 (EEA1) and Rab5 proteins.
During vesicle maturation, the pH gradually decreases due
to the activity of proton pumps and fusion with other
acidic vesicles. Early endosomes are moderately acidic
(pH ∼ 6.3–6.8) [21], and their cargo can be sorted either
for degradation via multivesicular bodies and late endo-
somes to lysosomes, or for recycling to the cell surface,
exosomes, or the trans-Golgi network [22, 23]. Transport
along the degradative pathway is associated with a gradual
decrease in pH (from 6.0 to 4.8 in Rab7-positive late endo-
somes and further to 4.5 in lysosomes [24]). Lysosomes
act as a storage site for hydrolases and other proteolytic
enzymes; they are the final destination on this pathway. In
recycling endosomes, the pH is maintained at ∼6.5 and
vesicles may be targeted to the outer membrane by Rab35
via fast recycling endosomes (~ 5min), or by Rab11 via
slow recycling endosomes (15–30min) [21]. Alternatively,
cargo may be transported from multivesicular bodies to
intraluminal vesicles, which may recycle to the cell surface
via a Rab27a/b-mediated pathway, leading to release of
cargo-loaded exosomes [25] (30–100 nm, often used by vi-
ruses during assembly and egress [26, 27]). Finally, at any
point, cargos may enter the trans-Golgi network and fol-
low the retrograde transport pathway guided by Rab9 [28].
The microenvironment within the vesicle during its
travel is precisely controlled, and viruses usually fuse with
the vesicular membrane at a certain time, i.e., when the
pH, membrane composition, and activity of cellular
proteases are optimal for fusion [22]. Virus dependence
on an acidic environment is often treated as a requirement
for endocytosis prior to fusion. Consequently, agents such
as ammonium chloride (NH4Cl) or bafilomycin A1 (Baf
A1), which increase intravesicular pH, are used to deter-
mine whether certain viruses are able to fuse to the cell
surface or whether endocytic internalization is required.
Here, we complement and expand the knowledge
about cell entry and intracellular trafficking of ZIKV.
Tracking of single virions using confocal microscopy
and separate labeling of the viral capsid and envelope
proteins revealed that virions that enter cells via CME
travel to late endosomal compartments and subsequently
fuse with the membrane. Blocking endosome acidifica-
tion using Baf A1 inhibited virus – cell fusion, leading to
trafficking of virus either along the degradative pathway
to the lysosomal compartments or its slow recycling to
the cell surface. Similar results were expected for
NH4Cl-treated cells; however, in this case, virions local-
ized to the cell surface, suggesting a very different mech-
anism of action. Surprisingly, it appeared that NH4Cl
“rewired” the endosomal hub and altered virus traffick-
ing within the endocytic labyrinth.
Materials and methods
Virus and cells
African green monkey kidney (Vero) cells (ATCC number:
CCL-81; RRID:CVCL_0059) were maintained at 37 °C
under 5% CO2 in standard medium [Dulbecco-modified
Eagle’s medium (DMEM, Thermofisher Scientific, Poland,
Poland) supplemented with 3% heat-inactivated fetal bo-
vine serum (FBS, Thermofisher Scientific, Poland), 100 U/
ml penicillin and 100 μg/ml streptomycin (Immuniq,
Poland)] with addition of 5 μg/ml ciprofloxacin.
ZIKV H/PF/2013 strain acquired from European Virus
Archive [29] was propagated in Vero cells under standard
medium. After 3 days of infection at 37 °C, virus-containing
medium was collected and titrated. As a control,
mock-infected Vero cells were subjected to the same pro-
cedure. Virus and mock aliquots were stored at − 80 °C.
Virus titration was performed on confluent Vero cells on a
96-well plate, according to the Reed–Muench method [30].
Inhibitors
Amantadine (1-adamantylaminean, AMTD; Sigma Al-
drich, Poland) was used at 400 μM as clathrin-coated pit





A1; Sigma Aldrich, Poland] was used at 100 nM as a vacuolar
type H+-ATPase inhibitor that hampers endosome acidifica-
tion [32]. Camostat [4-[[4-[(aminoiminomethyl)amino]
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benzoyl]oxy] benzeneacetic acid 2-(dimethylamino)-2-ox-
oethyl ester methanesulfonate, cam; Sigma Aldrich, Poland]
was used at 100 μM as a serine protease inhibitor [33].
Decanoyl-arg-val-lys-arg-chloromethylketone (CMK; Sigma
Aldrich, Poland) was used at 50 μM as furin inhibitor [34].
Dynasore [3-hydroxynaphthalene-2-carboxylic acid (3,4-dihy-
droxybenzylidene) hydrazide, Dyn; Abcam, UK] was used at




4-guanidinobutylamide (E64; Sigma Aldrich, Poland)
was used at 100 μM as a cysteine protease inhibitor
[33]. MitMAB (tetradecyltrimethylammonium bromide,
MM; Abcam, UK) was used at 20 μM as an inhibitor
that targets dynamin-phospholipid interaction [36].
NH4Cl (Bioshop, Poland) was used at 50 mM as an
intracellular alkalizing agent [37, 38]. PitStop 2 [N-
[5-[4-bromobenzylidene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl]
naphthalene-1-sulfonamide, PtS; Abcam, UK] was used at
50 μM as an inhibitor of ligand association with clathrin’s
amino terminal domain [39].
Immunostaining
Vero cells were seeded on glass slides in a cell culture
plate and cultured in standard medium for two days at
37 °C. Upon experimental procedure, the cells were fixed
with ice-cold 4% formaldehyde in PBS for 20 min at
room temperature, washed with PBS and permeabilized
with 0.5% TWEEN-20 for 10 min at room temperature.
Afterwards, non-specific binding sites were blocked
overnight at 4 °C with 5% BSA and slides were incubated
for 2 h at room temperature with primary anti-ZIKV
antibodies (specific to envelope protein (Merck Milli-
pore, Poland) or capsid protein (kind gift from prof. Jas-
soy, Institut für Virologie, Leipzig, Germany) diluted
1:100 in 3% BSA in PBS. To visualize host cell proteins,
slides were incubated with primary antibodies against
clathrin, EEA1, Rab7, LAMP1, Rab11, Rab27 and Rab35
[goat anti-clathrin HC (RRID:AB_2083170), rabbit
anti-EEA1 (RRID:AB_2277714) and rabbit anti-Rab7
(RRID:AB_2175483) polyclonal antibodies from Santa
Cruz Biotechnology, Poland, rabbit anti-Rab11A (RRI-
D:AB_2173458) polyclonal antibody from Proteintech,
UK, rabbit anti-Rab27A monoclonal antibodies from
Cell Signaling Technology, Poland, rabbit anti-Rab35
polyclonal antibody from Novus Biologicals, Poland,
rabbit anti-LAMP1 (RRID:AB_2134611) polyclonal anti-
body from Thermofisher Scientific, Poland] diluted
1:100 in 3% BSA in PBS, together with anti-ZIKV anti-
bodies. Next, the cells were incubated for another 1 h
with Alexa Fluor 488-labeled goat anti-mouse IgG (RRI-
D:AB_2534069, Thermofisher Scientific, Poland) or
Alexa Fluor 488-labeled rabbit anti-mouse IgG (RRI-
D:AB_2534106, Thermofisher Scientific, Poland) diluted
1:200 in 3% BSA in PBS. For staining of host cell
Fig. 1 Co-localization between ZIKV and clathrin-dependent endocytosis markers. Confocal images of Vero cells showing co-localization of ZIKV
envelope protein and clathrin (upper) or EEA1 (lower) at different time points p.i. Respective time points are indicated at the top of each column.
Control denotes mock-infected cells, stained with anti-ZIKV envelope antibodies and rabbit isotype antibodies (control for staining of cellular
proteins). The virus is visualized in green, clathrin and EEA1 are shown in red, and nuclei are presented in blue. Scale bar = 10 μm. Co-localization
parameters: r – Pearson’s coefficient; M2 - Manders’ coefficient M2 (the virus overlapping with clathrin/EEA1)
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proteins also Alexa Fluor 546 goat anti-rabbit secondary
antibodies (RRID:AB_2534077, Thermofisher Scientific,
Poland) or Alexa Fluor 546 donkey anti-goat secondary
antibodies (RRID:AB_2534103, Thermofisher Scientific,
Poland) diluted 1:200 were added to the mix. In experi-
ments focused on siRNA silencing and inhibitors’ influ-
ence on virus internalization, the cell surface was
labelled by Atto 633-phalloidin (Thermofisher Scientific,
Poland) diluted 1:50 in PBS for 1 h at room temperature.
Nuclei were stained with DAPI (RRID:AB_2629482,
Thermofisher Scientific, Poland) diluted 1:10000 in PBS.
At the end of immunostaining procedure slides were
thoroughly washed with 0.5% TWEEN-20 in PBS.
Stained slides were mounted in ProLong Diamond anti-
fade medium (Thermofisher Scientific, Poland) and
stored at 4 °C.
Staining of living cells
Vero cells were seeded on 35 mm glass bottom dishes
and cultured in standard medium for two days at 37 °C.
Afterwards, the cells were washed with PBS and incu-
bated in standard medium containing 50 nM Lyso-
Tracker™ Red DND-99 (Thermofisher Scientific, Poland)
for 90 min at 37 °C to visualize acidic organelles. Next,
the medium was discarded, and cells were overlaid with
BafA1/NH4Cl-containing or control standard medium
and observed for 30 min with a fluorescence microscope.
The first images (“0 min”) were acquired in < 1 min upon
treatment of the cells with the two above mentioned
agents.
Fluorescence and confocal microscopy
Images of living cells were acquired using EVOS FL Im-
aging System (Thermofisher Scientific, Poland) with 60×
oil immersion lens. Images of fixed cells were taken
under a ZEISS LSM 710 (version 8.1) confocal micro-
scope with 40× oil immersion lens and ZEN 2012 SP1
(black edition, version 8.1.0.484). Image processing was
performed with ImageJ FIJI (RRID:SCR_002285,
Fig. 2 Inhibition of ZIKV entry to clathrin-depleted cells. (a) Confocal analysis of ZIKV localization 10 min p.i. in Vero cells. vØ – ZIKV-infected, non-
transfected cells; v + si – ZIKV-infected, clathrin-specific siRNA transfected cells; v + sc – ZIKV-infected, scrambled siRNA transfected cells; v + sh –
ZIKV-infected, sham transfected cells; mock – mock-infected, non-transfected cells. ZIKV envelope protein is visualized in green and nuclei are
shown in blue. Scale bar = 10 μm. (b) Co-localization between ZIKV envelope and clathrin presented as Manders’ coefficient M2 for control and
clathrin-depleted Vero cells inoculated with ZIKV. The data is presented as mean ± SD. To determine the significance of differences between
compared groups, single-factor analysis of variance (ANOVA) was applied. P values < 0.05 were considered significant. One asterisk (*) identifies
adjusted P values between 0.01 and 0.05, two asterisks (**) identify adjusted P values between 0.01 and 0.001, three asterisks (***) identify
adjusted P values between 0.001 and 0.0001. (c) Western blot analysis of the efficiency of siRNA-dependent clathrin silencing (clathrin expression
in Vero cells compared to GAPDH expression in these cells). M – BlueStar prestained protein marker; Ø – normal non-transfected Vero cells
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National Institutes of Health, Bethesda, Maryland,
USA). Co-localization parameters (Pearson’s and
Manders’ coefficients) were calculated using JaCop
plugin [40].
Flow cytometry
Vero cells were seeded in a 6-well cell culture plate and
cultured in standard medium for two days at 37 °C. Upon
experiment, the cells were fixed, permeabilized, blocked
and immunostained with primary antibodies specific to
viral envelope protein (Merck Millipore, Poland) and sec-
ondary rabbit anti-mouse antibodies labeled with Alexa
Fluor 488 (RRID:AB_2534106, Thermofisher Scientific,
Poland), as indicated in Immunostaining section. Propor-
tion of ZIKV-infected cells (corresponding to the median
fluorescence of the analyzed cells population) was evalu-
ated with flow cytometry using FACSCalibur
(RRID:SCR_000401, Becton Dickinson, Poland). Cell
Quest software (RRID:SCR_014489, Becton Dickinson,
Poland) was used for data processing and analysis.
Cell viability
Cells were seeded on 96-well plates and cultured in standard
medium for two days at 37 °C. Afterwards, the cells were
washed with PBS, overlaid with standard medium supple-
mented with inhibitor or control and further incubated for
3 days at 37 °C. Cell viability was examined using XTT Cell
Viability Assay (Biological Industries, Poland), according to
the manufacturer’s protocol. Briefly, the medium was
discarded and 50 μl of fresh standard medium with
50 μl of the activated XTT solution was added to each
well. After 2 h incubation at 37 °C, the supernatant
was transferred onto a new, transparent 96-well plate
and signal from formazan derivative of tetrazolium
dye was read at λ = 490 nm using colorimeter (Tecan
i-control Infinite 200 Microplate Reader, 1.5.14.0).
The obtained results were further normalized to the
control, where cell viability was set to 100%.
Virus yield
Virus detection and quantification was performed using
reverse transcription (RT) followed by quantitative
real-time PCR (qPCR). Viral RNA was isolated from cell
culture supernatant 3 days post-infection (p.i.) using
Viral DNA / RNA Kit (A&A Biotechnology, Poland),
while reverse transcription was carried out with High
Capacity cDNA Reverse Transcription Kit (Thermofisher
Scientific, Poland), according to manufacturers’ proto-
cols. To assess virus yield, DNA standards were sub-
jected to qPCR along with the cDNA acquired from the
isolated samples. qPCR was performed using KAPA
PROBE FAST qPCR Master Mix (Kapa Biosystem,
Poland), ZIKV-specific primers (5′-TTG GTC ATG
Fig. 3 Inhibition of ZIKV infection in Vero cells by chemical agents blocking clathrin-mediated endocytosis. Vero cells pre-treated with CME
inhibitors were infected with ZIKV and viral yield was assessed 3 days p.i. Virus yield (RT-qPCR) is presented on the left side of the graph, while on
the right side toxicity of the compounds is visualized (XTT assay). mock – mock-infected cells; vØ – ZIKV-infected cells; AMTD – 400 μM
amantadine, Dyn – 100 μM dynasore, MM – 20 μM MitMab, PtS – 50 μM PitStop; control – inhibitor-untreated, non-infected cells. The data is
presented as mean ± SD. To determine the significance of differences between compared groups, single-factor analysis of variance (ANOVA) was
applied. P values < 0.05 were considered significant. One asterisk (*) identifies adjusted P values between 0.01 and 0.05, two asterisks (**) identify
adjusted P values between 0.01 and 0.001, three asterisks (***) identify adjusted P values between 0.001 and 0.0001
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ATA CTG CTG ATT GC-3′ and 5′-CCT TCC ACA
AAG TCC CTA TTG C-3′) and probe (5′-CGG CAT
ACA GCA TCA GGT GCA TAG GAG-3′) labelled with
FAM (6-carboxyfluorescein) and TAMRA (6-carboxyte-
tramethylrhodamine). Rox was used as a reference dye.
The signal was recorded and analysed using 7500 Fast
Real-Time PCR System (Thermofisher Scientific,
Poland).
siRNA silencing
Control (scrambled) siRNA (sc-44,237) and pooled siR-
NAs targeting heavy chain of clathrin (sc-35,067) were
obtained from Santa Cruz Biotechnology, Poland. siRNA
specific to simian Rab35 mRNA (GenBank sequence ID:
XM008004920.1) was designed and synthesized by Ther-
mofisher Scientific, Poland.
Vero cells cultured for 1 day in antibiotic- and
serum-depleted standard medium on a 6-well plate
were transfected with appropriate siRNAs using Lipo-
fectamine RNAiMAX (Thermofisher Scientific,
Poland). The procedure was performed according to
the manufacturer’s instructions and repeated 24 h
later to enhance the silencing effect. The efficiency of
the procedure was assessed by Western blotting 24 h
later (at the same time as microscopic studies on
virus subcellular localization).
Fig. 4 Co-localization of ZIKV with Rab7 and Rab11 marker proteins 10–15min p.i.
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Western blot analysis
Cells were harvested in RIPA buffer (1 h, 4 °C; Ther-
mofisher Scientific, Poland) supplemented with 0.5 M
EDTA and protease inhibitors cocktail (cOmplete
Tablets, Roche, Poland)]. Protein concentration was
assessed with Pierce BCA Protein Assay Kit (Thermo-
fisher Scientific, Poland), according to manufacturer’s
protocol. Samples containing equal amounts of pro-
teins were mixed with SDS-PAGE Sample Buffer (0.5
M Tris, pH 6.8, 10% SDS, 50 mg/ml DTT), denatured
for 10 min at 95 °C and separated by SDS-PAGE
electrophoresis. Subsequently, proteins were electro-
transferred onto a PVDF membrane (1.5 h, 100 V;
Amersham, Poland). The non-specific binding sites on
the membrane were blocked for 1 h at room
temperature with 10% milk (Bioshop) in Tris-buffered
saline supplemented with 0.25% TWEEN-20 (Bioshop,
Poland) (TBST) and incubated with primary anti-
bodies specific to clathrin or Rab35 [rabbit
anti-clathrin heavy chain polyclonal antibody, RRI-
D:AB_10695306, Cell Signaling Technology, Poland;
rabbit anti-Rab35 polyclonal antibody, Novus Biologi-
cals, Poland] diluted 1:500 or 1:1000 (for clathrin and
Rab35, respectively) in 3% BSA in TBST overnight at
4 °C and additionally for 1 h at room temperature; or
with primary antibodies specific to GAPDH (rabbit
anti-GAPDH antibodies, RRID:AB_561053, Cell Sig-
naling Technology, Poland) diluted 1:5000 in 3% BSA
in TBST for 1 h at room temperature. After being
washed in TBST, the membrane was incubated with
HRP-labelled anti-rabbit IgG antibody (RRI-
D:AB_257896, Sigma Aldrich, Poland) diluted 1:20,000
in 3% BSA in TBST for 1 h at room temperature. Fi-
nally, the proteins were visualized with chemilumines-
cence, using the ECL system (Amersham, Poland).
Co-localization assay
Vero cells were seeded in standard medium on glass
slides in 12-well plates. After 2 days, 2 h prior to infec-
tion, cell culture medium was replaced with
serum-depleted standard medium. Next, cells were
cooled down to 4 °C, overlaid with 100 μl of non-diluted
ZIKV stock (TCID50 ranging from 1000,000 to
10,000,000/ml, which approximately corresponds to
MOI = 1.75–17.5 and 7 × 105–7 × 106 PFU/ml) and incu-
bated for 30 min at 4 °C to synchronize cargo particles
entry from the cell surface. Subsequently, after incuba-
tion at 37 °C (exact times indicated for each experiment)
the cells were fixed, permeabilized, blocked and immu-
nostained for viral and cellular proteins, as indicated in
Immunostaining section.
Fig. 5 Cellular proteases and ZIKV. Vero cells were treated with proteases inhibitors (as outlined in the figure) and virus yield 3 days p.i. was
assessed using RT-qPCR (left side of the graph); cytotoxity of inhibitors is presented on the right side of the graph (XTT assay). mock – mock
infected cells; vØ – ZIKV- infected cells; cam – 100 μM serine protease inhibitor camostat; E64–100 μM cysteine protease inhibitor E64; CMK –
50 μM furin inhibitor CMK; control – inhibitor-untreated, non-infected cells. The data is presented as mean ± SD. To determine the significance of
differences between compared groups, single-factor analysis of variance (ANOVA) was applied. P values < 0.05 were considered significant. One
asterisk (*) identifies adjusted P values between 0.01 and 0.05, two asterisks (**) identify adjusted P values between 0.01 and 0.001, three asterisks
(***) identify adjusted P values between 0.001 and 0.0001
Owczarek et al. Cell Communication and Signaling           (2019) 17:41 Page 7 of 19
Virus inhibition assays
For visualization of virus subcellular localization during
experiments with agents interfering with virus traffick-
ing, Vero cells were cultured in standard medium on
glass slides in 12-well plates for 2 days and pre-treated
with a particular inhibitor 1 h prior to infection. After-
wards, the cells were cooled down to 4 °C, overlaid with
100 μl of non-diluted ZIKV stock (TCID50 ranging from
1000,000 to 10,000,000/ml, which approximately corre-
sponds to MOI = 1.75–17.5 and 7 × 105–7 × 106 PFU/ml)
in the presence of inhibitory agents and incubated for
another 30 min at 4 °C to synchronize cargo internaliza-
tion. Subsequently, the virus-overlaid cells were warmed
up to 37 °C. At indicated for each experiment time
points, cells were washed with PBS, fixed, permeabilized,
blocked and immunostained for viral and actin
cytoskeleton proteins as indicated in Immunostaining
section. Identical procedure was carried out for
visualization of virus particles in cells depleted of certain
proteins with siRNAs.
To test the influence of compounds on virus adhesion,
Vero cells cultured in standard medium in a 6-well plate
for 2 days were cooled down to 4 °C, overlaid with 100 μl
of ice-cold non-diluted ZIKV stock (TCID50 ranging from
1000,000 to 10,000,000/ml, which approximately corre-
sponds to MOI = 1.75–17.5 and 7 × 105–7 × 106 PFU/ml)
and incubated for another 2 h at 4 °C. Further, cells were
rinsed twice with ice-cold PBS. The cells were fixed,
permeabilized, blocked, immunostained and analyzed with
flow cytometry, as described in Flow cytometry section.
For assessment of the inhibitors’ influence on viral
replication, Vero cells were cultured in standard
Fig. 6 Endosome acidification in living cells treated with Baf A1 and NH4Cl. Vero cells were incubated with LysoTracker™ Red DND-99 for 90 min
at 37 °C and overlaid with BafA1, NH4Cl or control medium (Ø) and signal was recorded for 30 min with a fluorescence microscope. (a) Images
acquired at the beginning (0 min) and by the end (30 min) of incubation. (b) Mean fluorescence of the LysoTracker™ Red DND-99 based on the
set of xy images collected every 10 s in a 30min period. The data is presented as mean ± SD. To determine the significance of differences
between compared groups, single-factor analysis of variance (ANOVA) was applied. P values < 0.05 were considered significant. One asterisk (*)
identifies adjusted P values between 0.01 and 0.05, two asterisks (**) identify adjusted P values between 0.01 and 0.001, three asterisks (***)
identify adjusted P values between 0.001 and 0.0001
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medium in 96-well plates for 2 days and pre-treated
with a selected agent 1 h prior to infection. Virus at
TCID50 of 800/ml (which approximately corresponds
to MOI = 0.0014 and 550 PFU/ml) was overlaid on
the cells in the presence of inhibitors and samples
were incubated for 2 h at 37 °C. Wells were washed
thrice with PBS and incubated at 37 °C in standard
medium supplemented with inhibitors. 3 days p.i. cul-
ture supernatants were collected, viral RNA was iso-
lated and its yield was quantified with RT-qPCR.
Whether the procedure was modified, it is described
in the results section.
Fig. 7 Baf A1 and NH4Cl inhibit ZIKV infection. Vero cells pre-treated with intracellular agents hampering endosome acidification were infected
with ZIKV and viral yield was assessed at 3 days p.i. RT-qPCR results are presented on the left side of the graph. Right side of the graph shows
viability of cells, as determined by an XTT assay. Mock – mock infected cells; vØ – ZIKV- infected cells; NH4Cl – 50mM NH4Cl; BafA1–100 nM
bafilomycin A1; control – inhibitor-untreated, non-infected cells. The data is presented as mean ± SD. To determine the significance of differences
between compared groups, single-factor analysis of variance (ANOVA) was applied. P values < 0.05 were considered significant. One asterisk (*)
identifies adjusted P values between 0.01 and 0.05, two asterisks (**) identify adjusted P values between 0.01 and 0.001, three asterisks (***)
identify adjusted P values between 0.001 and 0.0001
Fig. 8 Increased number of virions trapped in the endosomal hub in cells treated with Baf A1, but not NH4Cl. Confocal analysis of ZIKV entry to
Vero cells in the presence of intracellular agents hampering endosome acidification. Following 1 h pre-treatment with 100 nM Baf A1 or 50 mM
NH4Cl the cells were infected with ZIKV and fixed 40min p.i. Baf A1 - ZIKV-infected Baf A1-treated cells; NH4Cl - ZIKV-infected NH4Cl -treated cells;
vØ - ZIKV-infected inhibitor-untreated cells; mock – mock-infected, inhibitor-untreated cells. ZIKV envelope protein is visualized in green, actin
cytoskeleton stained in red to show the cell boundaries and nuclei are shown in blue. Scale bar = 10 μm. Upper panel – xy projections; bottom
panel – xz projections
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Statistical analyses
Each experiment was performed at least twice in tripli-
cate. Chart bars represent mean ± SD. The significance
of differences between compared groups was determined
by Single-Factor Analysis of Variance (ANOVA); p
values < 0.05 were considered significant.
Results
ZIKV enters Vero cells via clathrin-dependent endocytosis
First, we asked whether ZIKV enters Vero cells via
CME, as reported for other in vitro systems. We exam-
ined co-localization of virions and cellular proteins (cla-
thrin, caveolin, endophilin, EEA1) at several time points
post-infection (p.i.). Co-localization of ZIKV with cla-
thrin was observed at 2–10min p.i. and coincided with
co-localization of virus with the early endosomal marker
EEA1 (Fig. 1). No co-localization with caveolin or endo-
philin was observed (data not shown).
As co-localization rates were not very high (Pearson’s
coefficient ranging from 0.103 to 0.216 and Manders’ co-
efficients up to 0.384), we carried out a complementary
study to validate the results. Subcellular localization of
ZIKV in Vero cells in which clathrin expression was
transiently silenced was examined. In this model virions
were retained on the surface of clathrin-depleted cells
even at 10 min p.i.; by contrast, control cells showed
normal expression of clathrin and were permissive for
ZIKV entry (Fig. 2).
To prove that clathrin-dependent endocytosis is the
main route of ZIKV internalization in Vero cells, we
Fig. 9 Baf A1 blocks virus-cell fusion. Co-localization between ZIKV and subcellular marker proteins in Baf A1-treated Vero cells 15 min p.i.
Confocal images of 100 nM Baf A1-treated ZIKV-infected Vero cells presenting co-localization between ZIKV capsid or envelope proteins and Rab7,
Rab11 and LAMP1 at 15 min p.i.. Rab7 – late endosomes marker protein, Rab11 – slow recycling endosomes marker protein, LAMP1 – lysosomes
marker protein. ZIKV proteins are visualized in green, cellular proteins in red and nuclei are shown in blue. Co-localization coefficients for the
representative presentations are indicated in the bottom left corners of the respective images; r – Pearson’s coefficient; M2 - Manders’ coefficient
M2 (the virus overlapping with Rab7/Rab11/LAMP1). Scale bar = 10 μm
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examined the effects of CME inhibitors on virus rep-
lication. We selected compounds to target multiple
steps of the vesicle formation process. These included
PitStop (PtS), which inhibits association between li-
gands with the terminal domain of clathrin [39];
amantadine (AMTD), which stabilizes clathrin-coated
pits [31]; MitMAB (MM), which targets the
dynamin-phospholipid interaction [36]; and dynasore
(Dyn), which inhibits the GTPase activity of dynamin
and therefore impairs loss of loaded vesicle from the
cell surface [35]. We assessed the impact of each in-
hibitor on ZIKV infection by measuring the viral yield
Fig. 10 Intracellular ZIKV virions in cells treated with Baf A1 or NH4Cl. Ratio of ZIKV particles present inside cells and total number of ZIKV
particles, assessed from confocal images of Vero cells infected with ZIKV in the absence (vØ) or presence of 100 nM Baf A1 (Baf A1) or 50 mM
NH4Cl (NH4Cl). The data is presented as the mean ± SD
Fig. 11 Influence of NH4Cl on ZIKV adhesion to the host cells. Flow cytometry analysis of viral adhesion to cells in the presence of NH4Cl was
carried out. Vero cells pre-treated with 50 mM NH4Cl were overlaid with ZIKV stock and following 2 h incubation at 4 °C, they were fixed and ZIKV
was immunostained with Alexa Fluor 488. Graph shows median fluorescence normalized to control, which corresponds to the proportion of ZIKV-
positive cells in total cells population. vØ – inhibitor-untreated cells overlaid with ZIKV; NH4Cl –NH4Cl-treated cells overlaid with ZIKV; mock –
mock-overlaid inhibitor-untreated cells. The data is presented as mean ± SD. To determine the significance of differences between compared
groups, single-factor analysis of variance (ANOVA) was applied. P values < 0.05 were considered significant. One asterisk (*) identifies adjusted P
values between 0.01 and 0.05, two asterisks (**) identify adjusted P values between 0.01 and 0.001, three asterisks (***) identify adjusted P values
between 0.001 and 0.0001
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released from infected cells into the medium at 3 days
p.i. All compounds reduced the ZIKV yield signifi-
cantly (Fig. 3), suggesting that ZIKV enters the Vero
cells via the clathrin-dependent route, as reported for
human cells [10].
ZIKV fusion occurs in late endosomal compartment
Once in the endosomal hub, ZIKV has a plethora of
pathways by which it can reach the site of fusion with
the host cell membrane. Conditions within endosomal
compartments differ with respect to lipid/protein con-
tent and pH. To find out how the virus is trafficked
to reach the site of fusion, using confocal microscopy
we tracked two ZIKV structural proteins, the capsid
protein (virus core) and the membrane-bound
envelope protein. Co-localization of both viral pro-
teins with cellular proteins (Rab7 in late endosomes,
Rab11 in slow recycling endosomes, and LAMP1 in
lysosomes) was analyzed at 5–20 min p.i. (full set of
images is available in Additional file 1: Figure S1 and
Additional file 2: Figure S2). The most evident
co-localization of the ZIKV capsid was found with Rab7,
peaking at 10–15min p.i. (Fig. 4). However, the envelope
protein showed increased co-localization with both Rab7
and Rab11-positive structures at 15min p.i. (Fig. 4), sug-
gesting that slowly recycling endosomes may carry viral
proteins to the cell surface upon delivery of RNA to the
cytoplasm from late endosomes. Finally, no
co-localization with LAMP1 was found (Additional file 1:
Figure S1 and Additional file 2: Figure S2).
Fig. 12 Co-localization between ZIKV and subcellular marker proteins in NH4Cl-treated Vero cells 20 min p.i. Confocal images of 50 mM NH4Cl
ZIKV-infected Vero cells presenting co-localization between ZIKV capsid or envelope protein and Rab7, Rab11 and LAMP1 at 20min p.i.. Rab7 –
late endosomes marker protein, Rab11 – slow recycling endosomes marker protein, LAMP1 – lysosomes marker protein. ZIKV proteins are
visualized in green, cellular proteins in red and nuclei are shown in blue. Co-localization coefficients for the representative presentations are
indicated in the bottom left corners of the respective images; r – Pearson’s coefficient; M2 - Manders’ coefficient M2 (the virus overlapping with
Rab7/Rab11/LAMP1). Scale bar = 10 μm
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Role of cellular proteases during ZIKV infection
Upon identification of the fusion site, we next identi-
fied host factors taking part in this process. Virus es-
cape from the endosomal compartment usually occurs
upon activation of viral fusion proteins, which may be
triggered by environmental conditions or/and host
proteases [41]. Therefore, we examined the
importance of different host cell proteases. Vero cells
were treated either with a furin inhibitor (decanoy-
l-arg-val-lys-arg-chloromethylketone [CMK]), a serine
protease inhibitor (camostat [cam]), or a cysteine pro-
tease inhibitor (E64) under four different conditions:
(1) 1 h prior to infection; (2) 1 h prior to infection
and for 2 h during infection; (3) 1 h prior to infection
Fig. 13 Subcellular localization of ZIKV in Rab35-depleted cells upon NH4Cl treatment. (a) Confocal analysis of ZIKV localization 1 h p.i. in NH4Cl-
treated Vero cells. ZIKV envelope protein is visualized in green, actin cytoskeleton stained in red to show the cell boundaries and nuclei are
shown in blue. Scale bar = 10 μm. (b) Western blot analysis of the efficiency of siRNA-dependent Rab35 silencing (Rab35 expression in Vero cells
compared to GAPDH expression in these cells). M – BlueStar prestained protein marker; Ø – normal non-transfected Vero cells. (c) Graph
representing the percent of ZIKV particles present inside cells related to the total number of ZIKV particles, assessed from confocal images of
siRNA-transfected and all control Vero cells infected with ZIKV H/PF/2013 in the presence of 50 mM NH4Cl. v + NH4Cl - ZIKV-infected, NH4Cl-
treated, non-transfected cells; v + sh + NH4Cl - ZIKV-infected, NH4Cl-treated, sham transfected cells; v + sc + NH4Cl - ZIKV-infected, NH4Cl-treated,
scrambled siRNA transfected cells; v + si + NH4Cl - ZIKV-infected, NH4Cl-treated, Rab35-specific siRNA transfected cells; vØ - ZIKV-infected, NH4Cl-
untreated, non-transfected cells; mock - mock-infected, NH4Cl-untreated, non-transfected cells. The data is presented as the mean ± SD. To
determine the significance of differences between compared groups, single-factor analysis of variance (ANOVA) was applied. P values < 0.05 were
considered significant. One asterisk (*) identifies adjusted P values between 0.01 and 0.05, two asterisks (**) identify adjusted P values between
0.01 and 0.001, three asterisks (***) identify adjusted P values between 0.001 and 0.0001
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and for 72 h p.i.; and (4) 2 h p.i. to 72 h p.i.. Culture
supernatants were collected at 72 h p.i., and viral
RNA was isolated and quantified by RT-qPCR. As
shown in Fig. 5, infection was not affected by serine
and cysteine protease inhibitors; however, the furin
inhibitor led to a significant decrease in virus yield
when administered p.i., suggesting that furin or
furin-like enzymes play an important role during
ZIKV replication, assembly or egress.
Agents that increase endosomal pH hamper ZIKV entry
and infection
We know that for some flaviviruses cell entry is sensitive
to pH changes; therefore, we used two compounds that
increase intravesicular pH (Fig. 6) to check the pH de-
pendence of ZIKV entry. Vero cells were treated with
NH4Cl or Baf A1 1 h prior to infection. Next, cells were
infected with ZIKV in the presence of NH4Cl or Baf A1
for 3 days at 37 °C. RT-qPCR analysis revealed strong in-
hibition of infection (Fig. 7). Next, we used confocal mi-
croscopy to test whether the compounds indeed inhibit
virus entry. Cells were treated with either of the inhibi-
tors for 1 h and then incubated with ZIKV for 40 min in
the presence of the inhibitors. Confocal microscopy
revealed that viral particles in Baf A1-treated cells
were visible in the cytoplasm, probably trapped in the
endosomal hub and unable to undergo fusion (Fig. 8).
Interestingly, we observed a different intracellular
virus distribution in cells treated with NH4Cl. Only a
small number of ZIKV virions was visible in the cyto-
plasm, while ZIKV particles localized mainly to the
cell surface.
Baf A1 blocks virus-cell fusion
Baf A1 is thought to prevent endosome acidification,
thereby preventing viral fusion and protein activation.
Therefore, we tracked viral capsid and envelope proteins
separately to visualize their fate during cell entry. To do
this, we examined co-localization of these two viral com-
ponents with markers of different parts of the endoso-
mal hub (Rab7, Rab11, and LAMP1) in Baf A1-treated
cells at 5–20min p.i. (Additional file 3: Figure S3 and
Additional file 4: Figure S4).
As described above, in non-treated cells the ZIKV cap-
sid and envelope proteins travelled together to late
endosomes, where fusion occurs. While capsid proteins
Fig. 14 NH4Cl interfere with late stages of ZIKV infection. Vero cells were treated Baf A1 and NH4Cl in 3 settings: (pre + vir) prior to + during ZIKV
infection (t = 1 h + 2 h); (all) prior to, during and post-ZIKV infection (t = 1 h + 2 h + 72 h) or (post) post-ZIKV infection only (t = 72 h, starting from
the time point 2 h p.i.). 3 days p.i. viral RNA was isolated from medium and quantified with RT-qPCR. mock – mock infected cells; vØ – ZIKV-
infected cells; NH4Cl – 50mM NH4Cl; BafA1–100 nM bafilomycin A1; control – inhibitor-untreated, non-infected cells. To determine the
significance of differences between compared groups, single-factor analysis of variance (ANOVA) was applied. P values < 0.05 were considered
significant. One asterisk (*) identifies adjusted P values between 0.01 and 0.05, two asterisks (**) identify adjusted P values between 0.01 and
0.001, three asterisks (***) identify adjusted P values between 0.001 and 0.0001
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entered the cytoplasm, envelope proteins were slowly
re-traffic to the cell surface. In the presence of Baf A1,
fusion was blocked, and both components tended to
co-localize with Rab11- and LAMP-1-positive structures
at 15 min p.i. (Fig. 9), suggesting that in the presence of
Baf A1 viral particles do not fuse with the membrane of
the vesicle. Rather, they are destined to undergo degrad-
ation in lysosomes. However, some are transported back
to the cell surface via the slow recycling pathway.
NH4Cl hampers infection inducing fast recycling of virions
back to the cell surface
A very different confocal image was observed when
cells were treated with NH4Cl. In this case, few virus
particles were observed in the cytoplasm (in contrast to
Baf A1-treated cells, in which the number of internal-
ized virions was similar to that in control cells) (Fig. 10).
First, we used flow cytometry analysis to test whether
NH4Cl affects binding of ZIKV to the cell surface,
which would explain this phenomenon. As shown in
Fig. 11, NH4Cl had no significant impact on ZIKV
adhesion to cells.
Next, despite the low number of internalized viral par-
ticles, we examined their co-localization with cellular
markers (Additional file 5: Figure S5 and Additional file 6:
Figure S6). In NH4Cl-treated cells, both the capsid and
envelope proteins co-localized with Rab7 (Fig. 12), sug-
gesting that internalized virions follow their normal
entry route. Moreover, slightly increased co-localization
of Rab11 with the envelope protein, but not the capsid
protein, at 20 min p.i. (Fig. 12), may suggest that, at least
for these single virus particles, fusion actually occurs.
We observed that, in the presence of NH4Cl, although
the virus may enter the cell, the number of internalized
viruses was very small. Because the inhibitor did not
affect the virus-cell interaction, we hypothesized that the
observed phenomenon may result from extensive an-
terograde transport. We did not observe co-localization
with Rab27; therefore, we excluded the role of exosomes
in NH4Cl-redirected virus trafficking (data not shown).
To verify the role of fast recycling endosomes, we used a
different approach. Because it was very difficult to
visualize this rapid process, we examined subcellular
localization of ZIKV upon NH4Cl treatment of Vero
cells in which expression of Rab35, a marker protein that
guides endosomes to the fast recycling track, was transi-
ently silenced. In the presence of NH4Cl, the majority of
virions localized to the cell surface of control and scram-
bled siRNA-transfected cells, whereas those in cells
transfected with Rab35-specific siRNA were retained
within the cell (trapped near the cell surface) until 1 h
p.i. (Fig. 13). This observation led us to conclude that
NH4Cl impairs ZIKV infection at an early stage by redir-
ecting virions back to the cell surface.
NH4Cl-induced re-modelling of intracellular trafficking:
effects on viral replication, assembly, and egress
Intracellular trafficking is important for virus replication,
not only at the early stages but also during virus assem-
bly and egress. The data regarding NH4Cl-mediated re-
modeling of the endosomal hub led us to hypothesize
that the compound may also interfere with the late
stages of infection. To confirm this, Vero cells were in-
fected for 2 h with ZIKV under normal conditions (i.e.,
in the absence of pH-modifying agents). Afterwards,
cells were rinsed thrice with PBS and then incubated at
37 °C for 3 days in standard medium containing Baf A1
or NH4Cl. Although Baf A1 did not affect the viral yield,
NH4Cl led to a 6.5 log reduction (Fig. 14), highlighting
differences in the mode of action between these two
agents and identifying a role for NH4Cl during the late
stages of infection.
Discussion
During infection, viruses hijack the inward transport
machinery of the cell [42–45]. While some viruses are able
to fuse with the cell membrane and initiate infection
almost immediately after entry, others need to be ferried
long distances, e.g., during infection of neural cells [46–
49]. This study focused on events that occur after the
initial interaction between ZIKV and its cellular receptor.
As observed for other flaviviruses and for ZIKV in dif-
ferent in vitro models [10, 12, 14], our findings demon-
strate that ZIKV enters Vero cells by clathrin-dependent
endocytosis. Co-localization of viral particles with clathrin
was observed 2–10min p.i., as expected for CME. How-
ever, synchronization of virus entry was not ideal due to
the fact that the process was regulated by temperature;
the numerical co-localization rates were significant but
moderate (Fig. 1; Pearson’s coefficient ranging from 0.103
to 0.216 and Manders’ coefficients up to 0.384). To ensure
that the observed co-localization is not an artifact, com-
plementary studies, including clathrin silencing (Fig. 2) or
CME-specific inhibitors (Fig. 3), were carried out and con-
firmed our initial observations.
Subsequent to clathrin-dependent internalization, the
virus is encapsulated within the endosome prior to deliv-
ery to a precisely defined location. During transport, the
microenvironment within the maturing endosome
changes gradually; the falling pH, cellular proteases, al-
terations in the vesicle’s membrane content, and fluctua-
tions in redox potential affect the cargo. Viruses are
fine-tuned to become active only under conditions that
maximize the chances of a productive infection; there-
fore in most cases this event takes place at a precisely
defined site within the endosomal hub [50–58]. Tracking
single dengue virus particles revealed that they pass the
early endosomes and fuse predominantly with vesicle
membranes as they mature into late endosomes at 10–13
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min p.i. [42]. Our observations of ZIKV trafficking are
congruent with these findings; we noticed separation of
the ZIKV envelope and capsid protein trafficking routes
between 10 and 15min p.i. These two viral proteins were
seen together for the last time in Rab7-positive structures.
These results are also consistent with the data obtained
with a novel a novel surrogate-receptor approach de-
scribed by Rawle et al. [59]. Later the ZIKV envelope ap-
peared to be transported back to the cell surface via slow
recycling endosomes. The latter observation is striking,
because it is commonly believed that, after endocytosis,
viruses avoid leaving evidence of their presence on the
plasma membrane as this delays detection by immunosur-
veillance system [46].
Multiple studies on flaviviruses showed that to acquire
fusion competence the envelope proteins need to be
primed proteolytically at two sites [50, 60–62]. First
cleavage occurs during transport through the trans--
Golgi network, where a tight complex of prM and E pro-
teins on the surface of newly formed immature virion
undergoes a low pH-induced conformational change,
followed by cleavage by furin or a furin-like protease
[60, 61]. Consequently, mature infectious virions that
carry the dimeric E protein in a metastable conformation
are released from the cell [62]. The second event occurs
during endocytosis into a permissive cell; when the E
protein is exposed to low pH, it undergoes rearrangment
and enters a fusion-competent state [50].
To identify the factors that activate the ZIKV fusion
protein, we used two classes of protease inhibitors.
Inactivation of cysteine proteases (e.g., cathepsins)
and serine proteases did not affect the infection
process. However, furin inhibitors hampered the repli-
cation cycle, especially when present during the late
stages. This observation is consistent with a common
belief that furin in essential for maturation of ZIKV,
similarly as for other flaviviruses. Despite the fact that
ZIKV E and M proteins structures have been resolved
[63, 64] and furin-specific cleavage site in ZIKV se-
quences is present [65], no report showing the role of
furin during ZIKV replication is available (Fig. 5) [60,
65–72].
One may conclude that furin or a furin-like enzyme
activates progeny viruses, while no second protease is re-
quired during entry to susceptible cell (as reported for
other members of Flaviviridae family) [60, 61]. By con-
trast, some results advocating a role for furin during
virus maturation may be due to an artifact, linked to the
low specificity of the protease inhibitors used [73].
Here, we show that entry of ZIKV depends on the
endosomal pH, and that endosome acidification is a pre-
requisite for fusion. Because we wanted to map the entry
of a single virion into the cell, we used two agents com-
monly used to assess virus dependence on acidic
environments. NH4Cl is a water-soluble salt of ammonia
that diffuses into the endosome and acts as a proton
sink, thereby inhibiting acidification of the endosome
[74]. The second compound, Baf A1, is a vacuolar type
H+-ATPase inhibitor that binds to the V0 sector subunit
c of the ATPase complex and inhibits H+ translocation,
thereby blocking endosome acidification [75]. Even
though the outcome of both treatments was similar, the
mechanism of action appeared to be very different.
In the presence of Baf A1, ZIKV particles were inter-
nalized and trafficked to the late endosomal compart-
ment. However, due to altered pH in the vesicles, virions
were not able to enter a fusogenic state and remained
trapped in the endosomes, which seemed to progress
slowly to lysosomes. Partial degradation and, to a lesser
extent, slow recycling to the cell surface are probably re-
sponsible for removal of the degradation products, so
that whole virions share the fate of the envelope protein.
By contrast, in the presence of NH4Cl the majority of vi-
rions are retained on the cell surface, which suggests
limited virus attachment/entry. First, we confirmed that
the virus–receptor interaction was not affected by the
basic compound; no alterations were observed. Conse-
quently, potential causes of such a phenomenon include
limited internalization or re-trafficking to the cell sur-
face. A limited number of virions localizing inside the
cells meant the we could not obtain credible results
from co-localization assays. Because no significant in-
crease in co-localization with the slow recycling endo-
some marker Rab11 was observed in NH4Cl-treated
cells, we tried to inhibit the fast recycling machinery by
transiently transfecting Vero cells with siRNAs targeting
the fast recycling endosome marker Rab35. Depleting
Rab35 resulted in retention of virions inside the cell,
showing that the NH4Cl-mediated inhibition results
from rewiring of the endosomal hub rather than a sim-
ple increase in endosomal pH.
Conclusions
To summarize, we mapped the entry route of ZIKV
using Vero cells as the research model. The results
are consistent with data on ZIKV entry into other cell
types including primary cells, suggesting that the virus
uses a universal entry mechanism. First, the virus uses
CME to enter the cell, and then travels through the
endosomal compartment to reach the late endosomes
prior to fusion. Subsequently, the viral envelope tends
to recycle to the cell surface. While it is essential that
progeny viruses are primed by furin-like enzymes dur-
ing assembly, entry seems to be protease-independent.
Interestingly, we noted that NH4Cl (believed to sim-
ply buffer the endosomal microenvironment) is in fact
re-directing the cargo and ejecting it into the extra-
cellular space. In our previous study we reported
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similar example of virus entry pathway redirection
[76], showing that external factors may affect virus
entry in an non-obvious way. We believe that the re-
sults presented herein not only increase our under-
standing of ZIKV biology, but also provide novel
molecular targets for future therapies.
Additional files
Additional file 1: Confocal images of ZIKV-infected Vero cells
presenting co localization between ZIKV structural proteins and Rab7,
Rab11 and LAMP1 at indicated time points p.i.. Rab7 – late endosomes
marker protein, Rab11 – slow recycling endosomes marker protein,
LAMP1 – lysosomes marker protein. ZIKV capsid and envelope proteins
are visualized in green, cellular proteins are shown in red and nuclei in
blue. Co‑localization coefficients indicated in the bottom left corners of
the images are presented as mean ± SD of at least two independent
experiments; r – Pearson’s coefficient; M2 - Manders' coefficient M2 (ZIKV
capsid/envelope protein overlapping with Rab7/Rab11/LAMP1).
Scale bar = 10 μm. Figure S1. Co-localization profile for ZIKV capsid
protein and subcellular marker proteins in Vero cells. (TIFF 2158 kb)
Additional file 2: Figure S2. Co-localization profile for ZIKV envelope
protein and subcellular marker proteins in Vero cell. (TIFF 2315 kb)
Additional file 3: Figure S3. Co-localization profile for ZIKV capsid protein
and subcellular marker proteins in Baf A1-treated Vero cells. (TIFF 2207 kb)
Additional file 4: Figure S4. Co-localization profile for ZIKV envelope protein
and subcellular marker proteins in Baf A1-treated Vero cells. (TIFF 1894 kb)
Additional file 5: Figure S5. Co-localization profile for ZIKV capsid protein
and subcellular marker proteins in NH4Cl-treated Vero cells. (TIFF 2103 kb)
Additional file 6: Figure S6. Co-localization profile for ZIKV envelope protein
and subcellular marker proteins in NH4Cl-treated Vero cells. (TIFF 1722 kb)
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